Elon Musk Neuralink’s First-Ever Human Brain Chip Implant
- Neuralink implants first brain chip successfully.
- Trials aim for thought-controlled devices in U.S. volunteers with disabilities.
- Controversies include monkey mistreatment, urging caution for candidates.
Elon Musk’s medical technology company Neuralink has announced the successful implantation of a brain chip in its first human subject.
Elon Musk took to Twitter to share the news, stating that the patient is recovering well and initial results show promising neuron spike detection.
Neuralink’s first human trial involved volunteers within the U.S. who are over 18 and have a disability, specifically focusing on individuals with quadriplegia caused by a cervical spinal cord injury or those with amyotrophic lateral sclerosis (ALS). The company’s goal is to assist people with disabilities by allowing them to operate electronic devices using their brains.
Revealed as Neuralink’s first product, called “Telepathy,” Musk explained that it enables control of phones, computers, and almost any device through mere thoughts. The initial users are expected to be individuals who have lost the use of their limbs, potentially revolutionizing communication and interaction for people with disabilities.
Neuralink’s Precise Robotically Implanted Brain-Computer Interface (PRIME) Study, launched last September, aims to assess the safety of the N1 brain implant and the R1 surgical robot designed for implantation. The study involves placing ultra-fine and flexible threads in the brain’s movement control region, with the N1 Implant transmitting signals wirelessly to an app that decodes movement intentions.
However, Neuralink has faced controversies in its development journey. A Wired report in September detailed torturous conditions endured by monkeys used in experiments, contradicting Musk’s earlier claims that none had died due to the company’s implants. The company has also faced investigations by the U.S. government for potential violations of animal welfare laws, raising concerns about the rushed timelines and the impact on live subjects.
While Neuralink has received approval from the U.S. Food and Drug Administration (FDA) to proceed with human trials, there remains reasonable apprehension about the company’s history with live subjects. The controversies surrounding animal experiments underscore the need for thorough consideration by potential candidates before volunteering for Neuralink’s brain chip implants.
